Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorGuangdong Provincial People's Hospital

About this trial

Coronary Heart Disease (CHD) is an ischemic heart disease caused by coronary atherosclerosis, and it is the leading cause of death from cardiovascular diseases worldwide. Weight loss in obese patients can significantly improve metabolic indicators such as dyslipidemia and insulin resistance; therefore, weight loss may become a target for improving the prognosis of obese patients with coronary heart disease. This study is a multicenter, randomized controlled clinical trial aimed at evaluating the effect of software-based healthy weight loss guidance (personalized diet + exercise intervention) in obese patients with coronary heart disease. It is expected that 136 patients will be enrolled in hospitals including Guangdong Provincial People's Hospital, with a total study duration of 1 year.

Eligibility criteria

Qualifiers

Age range: 18-65 years old .

History of coronary heart disease confirmed by coronary angiography or coronary CTA, showing ≥50% stenosis in at least one major coronary artery (left main coronary artery, left anterior descending artery, left circumflex artery, right coronary artery); or a definite history of myocardial infarction, or prior coronary revascularization (PCI or CABG).

BMI: Body Mass Index (BMI) ≥ 28 kg/m²

Weight loss willingness: Has the intention to lose weight

Disqualifiers

Unstable angina pectoris or acute myocardial infarction occurring within the previous month;

Comorbid endocrine or neurological diseases, cancer, or a history of bariatric surgery that affect body weight; or long-term use of medications that impact body weight;

Comorbid diseases that affect exercise capacity, such as severe cardiopulmonary diseases or osteoarthritic conditions;

Comorbid diseases that affect diet, such as severe mental disorders, bulimia or anorexia nervosa, or cognitive dysfunction;

Trial design

Treatments tested in this trial

  • dietary regulation and structured exercise training

Treatment groups

140 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Guangdong Provincial People's Hospital

Lead sponsor

Yuebei People's Hospital

Collaborator

Guangzhou Red Cross Hospital

Collaborator

Zhongshan Hospital Of Traditional Chinese Medicine

Collaborator

Shenzhen Nanshan Institute of Chronic Disease Control

Collaborator

Dongguan Binhaiwan Central Hospital

Collaborator

The Eighth People's Hospital of Nanning

Collaborator

People's Hospital of Xinjiang Uygur Autonomous Region

Collaborator

Nanyang Central Hospital

Collaborator

The First People's Hospital of Yunnan

Collaborator

The First People's Hospital of Nanning

Collaborator